Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT

Revenues for CAPLIPOINT are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 0.00000
forwardPE 21.18781
debtToEquity 0.17400
earningsGrowth 0.23300
revenueGrowth 0.11200
grossMargins 0.60749
operatingMargins 0.31647
trailingEps 74.13000
forwardEps 0.00000

Caplin Point Laboratories Limited's Forward PE being in a good range indicates that the stock is valued appropriately based on its earnings. This suggests the stock is not overpriced and leaves room for growth, providing investors with an opportunity for potential appreciation in value.
CAPLIPOINT's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that CAPLIPOINT is well-positioned for sustained growth in both profits and revenue.
Positive gross and operating margins for Caplin Point Laboratories Limited demonstrate the company's profitability. These margins reflect strong financial performance, with efficient operations contributing to the company's ability to generate consistent profits.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT

CAPLIPOINT's price projections have gradually risen, indicating growing confidence in the company's prospects. This upward trend suggests that analysts expect CAPLIPOINT to continue performing well in the future.

Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


Analysts have maintained a buy bias for CAPLIPOINT, which could prompt investors to consider the stock as a viable investment. With this positive outlook, CAPLIPOINT is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.